Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

OBN Awards 2019 - Winners Recognised at Industry Leading Event


News provided by

OBN

08 Nov, 2019, 09:00 GMT

Share this article

Share toX

Share this article

Share toX

ABINGDON, England, Nov. 8, 2019 /PRNewswire/ -- OBN (UK) Ltd., the membership organisation that supports the life sciences industry, is delighted to announce the winners of the 2019 OBN Awards.

The Awards, which are in their 11th year, celebrate the best of UK life sciences – from outstanding scientific innovation within Biotech, Medtech and Digital Health, to the companies that support the industry and the fundraisers that make it happen. This year's event hosted an audience of over 250 life sciences industry leaders at the Oxford Examination Schools.

John Harris, CEO of OBN, said: "We received an incredible number of entries yet again this year, so competition has been really tough for all nominees. All our winners and finalists are truly innovative, at the very top of their respective sectors, and set a great example to the rest of the industry. We have introduced several new categories this year to reflect industry trends. The turn-out and support we have received is a true reflection of how buoyant our industry continues to be, and I would like to thank all our sponsors and supporters for helping us make the OBN Awards once again such a great success."

The winners of the awards are:

Best Start-up Biotech Company, kindly sponsored by James Cowper-Kreston

Winner – Grey Wolf Therapeutics

Develop next generation immunotherapies that illuminate non-responsive tumours for destruction by the immune system.

Best Start-up Medtech Company

Winner – Caristo Diagnostics

Develop a novel technology that can identify regions of inflammation around coronary arteries and which has the potential to transform the diagnostic power of routine coronary CT angiograms.

Most Transformative Digital Healthcare Company

Winner – Sensyne Health

Combine clinical artificial intelligence technology and ethically sourced, anonymised patient data to help provide better healthcare.

Best CRO

Winner - RSSL

Help world leading brands and SME's develop and supply products that are safe, innovative and of the highest quality.

Best Specialist CRO, kindly sponsored by ThermoFisher Scientific

Winner – Precision for Medicine, Oncology and Rare Disease

Provide personalised oncology and rare disease clinical operations with an emphasis on the application of biomarkers to drive improvements in clinical endpoints.

Best Emerging Medtech Company, kindly sponsored by BDO

Winner - Open Bionics

Build and develop the next generation of bionic limbs, turning disabilities into 'superpowers', starting with the Hero Arm.

Best Emerging Biotech Company, kindly sponsored by Precision For Medicine, Oncology and Rare Disease

Winner – NodThera

Developing a new class of potent and highly selective NLRP3 inflammasome inhibitors for the treatment of chronic inflammatory diseases.

Best Sector Support Organisation

Winner – UKI2S

The UK Innovation and Science Seed Fund, build and grow technology companies stemming from the UK's diverse research base.

Most Innovative Big Pharma Organisation, kindly sponsored by Milton Park

Winner - Johnson & Johnson Innovation

Has demonstrated some excellent collaborations, providing a wide range of platforms to support their internal and external pipeline of technologies which is positively impacting patient lives.

The BioSeed® 'One to Watch' Award, kindly sponsored by Mills & Reeve

Winner - Attomarker

Develop iPhone connected diagnostic technology to enable rapid and personal access to diagnostic tests conventionally carried out in analytical laboratories.

Best Established Biotech Company, kindly sponsored by World Courier

Winner - Bicycle Therapeutics

Exploit their proprietary phage display technology to select peptide-like 'Bicycles' for development into novel therapeutics.

Best Established Medtech Company

Winner – Endomag

Help tens of thousands of women across the world to access more accurate and less invasive breast cancer care.

Special Recognition Award

Winner - Sunil Shah, o2h for his rare vision and supportive ethos to the companies he invests in: offering support beyond cash alone, but also invaluable experience, contacts and personal time. He has an inspiring passion and enthusiasm for science and business.

About the OBN Awards – www.obn-awards.com

The OBN Awards, now in its 11th year, celebrates innovation and achievement across the UK Life Sciences Industry. We are proud that the awards remain independent with categories that cover Biotech, Medtech, and Digital Health and recognises achievements from emerging R&D companies to large pharma and life sciences investors.

OBN Awards 2018 Independent Judging Panel

Michel de Baar - Executive Director, BD&L Europe - MSD

Jon Bircher - Chief Commercial Officer - Cello Health

David Browning - CEO - Fixed-Phage

John Chaddock - VP Interim Head Neuroscience Therapeutic Area, Site Head - Ipsen Bioinnovation

Sue Charles - Managing Partner - Instinctif Partners

Bill Fleming - CFO - Ultromics

Peter Hamley - CSO - Samsara Therapeutics

John Harris - CEO - OBN

Jutta Heix - International Advisor - Oslo Cancer Cluster

Sarah Holland - VP Global Head of Licensing - Lonza

Ian Oliver - Partner - BDO

Carlos Pittol - Director - Clubb Capital

Jonathan Rohll - Head of Business Information - OBN

Clare Sarvary-Fourrier - SVP Clincal Operations - Europe - Precision for Medicine, Oncology & Rare Disease

Jason Slingsby - Head of Business Development - Oxford Biomedica

Robert Tansley - Investment Director - Cambridge Innovation Capital

Rebecca Todd - Investment Director - Longwall Venture Partners

About OBN

OBN is the Membership organisation supporting and bringing together the UK's emerging life sciences companies, corporate partners and investors. Our 400+ member companies are located throughout the UK and benefit from our networking, partnering, purchasing, advising and advocacy activities.

OBN delivers four World-Quality flagships events per annum:

BIOTRINITY®:

BioTrinity is Europe's leading Biopartnering and Investment conference, in London on 28 - 29 April 2020 (its 14th year).

www.biotrinity.com

BIOSEED®:

BioSeed is a unique platform for early-stage life sciences companies, TTO's, and Universities throughout Europe seeking equity investment from angels, HNW individuals, specialist crowd-funders, and PE / VC / Pharma funders genuinely interested in seed and Series A funding (London, 20 January 2020).

www.bioseed.eu

BIOFORWARD®:

BioForward is a high-quality international partnering conference providing a roadmap for R&D companies looking to achieve sustainable business growth.

www.bioforward.co.uk

OBN AWARDS:

This is the UK's leading life sciences awards event, celebrating innovation & outstanding achievement across the UK Life Sciences Industry.

www.obn-awards.com

Further information about OBN's tailored networking and partnering events, purchasing consortium, advice, consultancy services and advocacy activities is available on OBN's website www.obn.org.uk

Contacts:

Event enquiries:
Jane O'Driscoll
Head of Events, OBN 
jane.odriscoll@obn.org.uk  

Picture requests:

Rebecca Wilkes
Communications & Marketing Co-ordinator, OBN
rebecca.wilkes@obn.org.uk

Media enquiries:

Citigate Dewe Rogerson
Sylvie Berrebi
Sylvie.berrebi@citigatedewerogerson.com 

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.